The prevalent KRAS exon 2 c.35 G>A mutation in metastatic colorectal cancer patients: A biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens?-Reference-Cited by-同舟云学术

The prevalent KRAS exon 2 c.35 G>A mutation in metastatic colorectal cancer patients: A biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens?

Published:2015-03 Issue:3 Volume:93 Page:190-202
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Bruera Gemma,Cannita Katia,Tessitore Alessandra,Russo Antonio,Alesse Edoardo,Ficorella Corrado,Ricevuto Enrico

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference62 articles.

1. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol,2001

2. The epidermal growth factor receptor pathway: a model for targeted therapy;Scaltriti;Clin Cancer Res,2006

3. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance;McCubrey;Adv Enzyme Regul,2006

4. Cosmic 2005;Forbes;Br J Cancer,2006

5. ras oncogenes in human cancer: a review;Bos;Cancer Res,1989

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of Next-Generation Sequencing in the Surgical Management of Colorectal Liver Metastasis;Annals of Surgical Oncology;2023-06-14

2. Case Report: Long-term survival of a patient with advanced rectal cancer and multiple pelvic recurrences after seven surgeries;Frontiers in Oncology;2023-05-15

3. Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases;BMC Cancer;2022-06-16

4. The Effect of the Kirsten Rat Sarcoma Viral Oncogene Homolog (Kras) Proto-Oncogene, GTPase Genetic Polymorphism on the Safety and Efficacy of Bevacizumab Combination Treatment Regimens for Patients with Nonsquamous, Non-Small Cell Lung Cancer with Brain Metastases;Genetic Testing and Molecular Biomarkers;2022-05-01

5. Concurrent RAS and RAS/BRAF V600E Variants in Colorectal Cancer: More Frequent Than Expected? A Case Report;Frontiers in Oncology;2022-04-07